BCR-ABL activates STAT3 via JAK and MEK pathways in human cells-Reference-Cited by-同舟云学术

BCR-ABL activates STAT3 via JAK and MEK pathways in human cells

Published:2006-07 Issue:2 Volume:134 Page:171-179
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Coppo Paul,Flamant Stephane,Mas Veronique De,Jarrier Peggy,Guillier Martine,Bonnet Marie-Laure,Lacout Catherine,Guilhot Francois,Vainchenker William,Turhan Ali G.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2006.06161.x/fullpdf

Reference41 articles.

1. Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells

2. Stat3 as an Oncogene

3. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells

4. Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

5. New understanding of the pathogenesis of CML: a prototype of early neoplasia

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STAT3 Regulates the Redox Profile in MDA-MB-231 Breast Cancer Cells;Cell Biochemistry and Biophysics;2024-07-20

2. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery;Journal of Experimental & Clinical Cancer Research;2024-01-20

3. C-Myc inhibition intensified the anti-leukemic properties of Imatinib in chronic myeloid leukemia cells;Molecular Biology Reports;2023-11-04

4. CDK8/19 Inhibition Attenuates G1 Arrest Induced by BCR-ABL Antagonists and Accelerates Death of Chronic Myelogenous Leukemia Cells;2023-09-25

5. JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus;Genes;2023-05-24